BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Novartis AG (NVS) Considers Investment in Malaysia


11/5/2012 7:54:20 AM

Malaysia is currently in consideration by Novartis, the world's second largest pharmaceutical company, as a potential site for a healthcare biotechnology investment. In a statement today, Malaysian Biotechnology Corp (Biotech) said Novartis has continued to highlight its partnership with the Sarawak Biodiversity Centre to develop drug compound leads from microbial natural products. "As a further boost to the local healthcare bioeconomy scene, Novartis has broadened the range of their support from drug discovery projects to even potential funding for biomedical companies via their Novartis Venture Funds," it said. Biotech chief executive officer Datuk Dr Mohd Nazlee Kamal was quoted in the statement as saying the harmony of strategies, innovations and technologies would be a timely impetus in structuring potential growth, with bioeconomy being discussed in the BioMalaysia 2012 Conference and Exhibition.

Read at Business Times

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES